When was Precision Antibody founded?

Precision Antibody was founded in 2000.

Where is Precision Antibody located?

Precision Antibody is headquartered in Baltimore, United States.

How many employees does Precision Antibody have?

As of Apr 30, 2026, the latest employee count at Precision Antibody is 9.

Is Precision Antibody a funded company?

Precision Antibody is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Precision Antibody rank among its competitors?

Precision Antibody ranks 418th amongst 469 active competitors, of which 51 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Abingdon Health, which secured $4.4M in Oct, 2025.

Who are the top competitors of Precision Antibody?

Precision Antibody's top competitors include Anthem Biosciences, Patheon and KBI Biopharma. Among them, Abingdon Health secured the most recent funding round in October, 2025.

Precision Antibody - 2026 Company Profile & Competitors

Company Details

Custom antibody development and production services for research and diagnostic applications. They specialize in creating application-specific custom antibodies, including monoclonal and polyclonal antibodies, using innovative techniques. Services encompass the entire antibody development process, from antigen design and immunization to antibody production, purification, and characterization. They offer a range of services, including antibody sequencing, humanization, cell banking, and various functional assays. Their expertise supports diagnostic, biomarker, and therapeutic fields, providing tailored solutions for unique project requirements. They focus on delivering high-quality antibodies with fast turnaround times and personalized support, ensuring customer satisfaction and project success. They are AAALAC and OLAW accredited, emphasizing their commitment to quality and ethical practices. They offer custom antibody services, novel mono- & polyclonal antibody development, antibody production & purification, and antibody characterization.

Website: precisionantibody.com
Email ID: *****@precisionantibody.com

Key Metrics

Founded Year

2000

Location

Baltimore, United States

Stage

Unfunded

Ranked

418^th among 469 active competitors

Employee Count

9 as on Apr 30, 2026

Similar Companies

Nautilus Biotechnology & 231 more

View Precision Antibody's full profile

Precision Antibody has not raised any funding rounds yet.

Precision Antibody's employee count trend

Precision Antibody has 9 employees as of Apr 26. Here is Precision Antibody's employee count trend over the years:

Employee count trend for Precision Antibody

Uncover Precision Antibody's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Precision Antibody include Anthem Biosciences, Patheon and KBI Biopharma. Here is the list of Top 10 competitors of Precision Antibody, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Anthem Biosciences 2007, Bengaluru (India), Public	Developer of integrated contract research development and manufacturing services	$35.7M	Portsmouthtechnologiestrialsunit, True North ... & 7 others	77/100
2nd	Patheon 1974, Durham (United States), Acquired	Global CDMO providing integrated drug development, clinical trials, and manufacturing services	$141M	Frazier Healthcare Partners, JLL Partners ... & 3 others	75/100
3rd	KBI Biopharma 1996, Durham (United States), Acquired	Provider of protein formulation, process & cell line development, and cGMP services	$21M	Ballast Point Ventures, NCBiotech & 1 others	71/100
4th	Abingdon Health 2008, York (United Kingdom), Public	Developer of immunoassays for diagnostic purposes	$24.1M	Imperial Innovations, Mercia & 2 others	68/100
5th	Syngene 1993, Bengaluru (India), Public	Provider of contract research and manufacturing services for both small molecules and biologics	$85.9M	True North, ADIA & 8 others	66/100
6th	Nautilus Biotechnology 2016, Seattle (United States), Public	Developer of proteomics platform for drug development	$453M	Vulcan, Bain Capital Life Sciences & 7 others	65/100
7th	Abzena 2001, Cambridge (United Kingdom), Acquired	Provider of antibody discovery, cell line development, and bio analytics services	$67.1M	Imperial Innovations, Invesco Perpetual & 11 others	65/100
8th	Panacea Biotec 1984, Ambala (India), Public	Developer of biosimilars, vaccines and natural products	-	India Resurgence Fund, Department of Biotechnology ... & 1 others	64/100
9th	Somalogic 1999, Boulder (United States), Acquired	Developer of protein-based assays for life science research	$664M	ProQuest Investments, ICarbonX & 27 others	64/100
10th	Biognosys 2008, Schlieren (Switzerland), Acquired	Provider of proteomics service	$9.13M	Zurcher Kantonalbank, Redalpine & 6 others	63/100
418th	Precision Antibody 2000, Baltimore (United States), Unfunded	Custom antibody development and production services for research and diagnostic applications	-	-	19/100